Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial

Kim Papp*, Diamant Thaçi, Danielle Marcoux, Lisa Weibel, Sandra Philipp, Pierre Dominique Ghislain, Ian Landells, Peter Hoeger, Carol Kotkin, Kristina Unnebrink, Marieke Seyger, David A. Williams

*Corresponding author for this work
49 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences